Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan ...Middle East

Single-arm Phase III study in Japan evaluating leniolisib in patients aged 12 years and older with APDS, a rare primary immunodeficiency LEIDEN, The Netherlands, Aug. 9, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR)...

Hence then, the article about pharming announces first patient enrolled in phase iii clinical trial of leniolisib for the treatment of apds in japan was published today ( Wednesday 09/08/2023 - 08:05 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan )

Also on site :

• Paul Rudd Reveals the Unexpected Reason Why He Almost Lost His ‘Clueless’ Role
• Thousands of mutilated kids will sue ‘Mengele’ gender surgeons – Musk
• Numbrix 9 - February 1